cough medicine

Stop sign
Biotech

Roche culls cough candidate, pivots KRAS program in Q3 update

Roche axed the cough program as part of a wider pullback from prospects that fell short of the bar for further development.
Nick Paul Taylor Oct 23, 2024 6:35am
concept of job dismissal with puzzle pieces

After $2B acquisition, GSK sends some Bellus workers packing

Mar 22, 2024 11:08am
predictive analytics

GSK tips 12 blockbuster launches to soften HIV patent loss

Jan 31, 2024 7:45am
Image of a neon sign with the word no lit up next to an unlit yes

Merck’s cough drug gefapixant rejected by FDA for second time

Dec 21, 2023 5:38am
cough quarantine COVID sick cold flu

After Merck's cough drama, GSK knew what to do with Bellus asset

Nov 30, 2023 8:00am
Merck Co headquarters

UPDATE: FDA AdComm votes against Merck's cough med

Nov 17, 2023 4:53pm